Phenylalanine-restricted diets in the treatment of phenylketonuria.
نویسندگان
چکیده
Phenylalanine restriction has been used in the treatment of the metabolic and mental disorders of phenylketonuria with conflicting results. Bickel, Gerrard and Hickmans (1953) reported the first successful treatment of a child aged 31 who was observed for 12 months in hospital and at home. The biochemical abnormality of phenylpyruvic acid in the urine was corrected in this patient, but evidence of prolonged biochemical normality was not given, and, although the improvement in her mental condition was promising, prolonged psychological tests were not done. Woolf, Griffiths and Moncrieff (1955) reported studies of three further children for six to nine months, in whom satisfactory mental and biochemical improvements were found. Less conclusive advance in the mental state was observed by Armstrong and Tyler (1955) despite apparently normal biochemistry in the serum and urine in five children aged 9 months to 41 years. Confusion also persists regarding the longer-term effects of phenylalanine restriction on the physical, biochemical and mental states of these children and adequate criteria of control and assessment have not been clearly defined. Some workers have used synthetic diets with pure amino-acids; others have given casein hydrolysates low in phenylalanine as the source of nitrogen. The ages of the children treated have varied considerably, and the initial degree of mental defect has not always been clearly described. It is the purpose of the present paper to confirm that apparent biochemical normality can be obtained, with normal growth and physical development for long periods, using diets very severely limited in phenylalanine, and to assess critically the mental progress attained in a group of six children treated for up to three years with such diets.
منابع مشابه
آشنایی با فنیل کتونوری
Background: Phenylketonuria is an inherited metabolic disease. It is genetic disorder autosomal recessive type. It is caused by absent or deficiency Phenylalanine hydroxylase enzyme activity that converts Phenylalanine to Tyrosine. It leads to increasing Phenylalanine in the blood. Tyrosine is important for production of some neurotransmitters. So it caused deficiencies of dopamine and serotoni...
متن کاملPhenylketonuria Treatment’s Impact on Physical Growth: A Spanish Retrospective Longitudinal Study
Background: Phenylketonuria treatment based on phenylalanine-restricted diet has proven to be effective in preventing the development of long-term neurological damage. However, such diets have occasionally been reported to hinder normal development. Furthermore, to improve outcomes in these patients therapy based on administration of the cofactor BH4 has emerged. However, little is known about ...
متن کاملPhenylketonuria: protein content and amino acids profile of dishes for phenylketonuric patients. The relevance of phenylalanine.
Phenylketonuria is an inborn error of metabolism, involving, in most cases, a deficient activity of phenylalanine hydroxylase. Neonatal diagnosis and a prompt special diet (low phenylalanine and natural-protein restricted diets) are essential to the treatment. The lack of data concerning phenylalanine contents of processed foodstuffs is an additional limitation for an already very restrictive d...
متن کاملMolecular Diagnosis of Plasma Phenylalanine in Neonates with Phenylketonuria Disease Using Biological Sensors Based on Surface-Enhanced Raman Spectroscopy (SERS)
In this study, silver nanoparticles were chemically synthesized and deposited on glass substrates using a reducing agent of sucrose, at 50°C. Different characterizations including atomic force microscopy (AFM), field emission scanning electron microscopy (FESEM), and Raman spectroscopy were obtained to study silvery substrates. Then, the silvery substrates were used as the SERS substrates to de...
متن کاملPhenylketonuria from Genetics to Clinics: An Iranian Prospect
Phenylketonuria (PKU) is the most common autosomal recessive disorder of amino acid metabolism. Thedisease is caused mainly by mutations in the phenylalanine hydroxylase (PAH) gene, encoding phenylalaninehydroxylase (PAH) enzyme. The PAH enzyme deficiency results in the elevation of phenylalanine inthe blood, which may cause severe irreversible mental retardation in the affect...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Archives of disease in childhood
دوره 31 160 شماره
صفحات -
تاریخ انتشار 1956